**Core Concept**
The process of acetylation is an important aspect of drug metabolism, where a molecule is modified by the addition of an acetyl group. This process is primarily mediated by the enzyme N-acetyltransferase (NAT) in the liver. Certain drugs are metabolized through acetylation, which can affect their pharmacokinetics and pharmacodynamics.

**Why the Correct Answer is Right**
The correct answer is a drug that is not metabolized by the acetylation process. Drugs that undergo acetylation typically have a rapid onset of action and a short half-life. This is because acetylation is a rapid process that converts the drug into an inactive metabolite. The enzyme NAT is responsible for catalyzing this reaction, and genetic variations in the NAT gene can affect the rate of acetylation.

**Why Each Wrong Option is Incorrect**
* **Option A:** This drug is actually known to be metabolized by acetylation, which affects its efficacy and toxicity.
* **Option B:** This drug is not primarily metabolized by acetylation, but through other mechanisms such as oxidation or conjugation.
* **Option C:** This drug is indeed metabolized by acetylation, which influences its therapeutic effects and potential side effects.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that genetic variations in drug-metabolizing enzymes like NAT can lead to significant differences in drug response and toxicity among individuals. This is particularly relevant when prescribing medications that undergo acetylation, as altered acetylation rates can affect their efficacy and safety.

**Correct Answer: B. This drug is not primarily metabolized by acetylation, but through other mechanisms such as oxidation or conjugation.**